Merrill Lynch Depositor Inc. 6.0518% Index Plus Trust Series 2003-1 (IPB)
USD 25.2
(-4.18%)
USD 25.2
(-4.18%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | - | - | - | - | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
| Breakdown | 2021 Q4 | 2021 FY | 2020 FY | 2020 Q4 | 2019 Q4 | 2019 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3 Billion | - | - | -3 Billion | -3 Billion | - |
| Depreciation & Amortization | -392 Million | - | - | -392 Million | -392 Million | - |
| Deferred income taxes | -2.46 Billion | - | - | -2.46 Billion | -2.46 Billion | - |
| Stock-based compensation | -1.24 Billion | - | - | -1.24 Billion | -1.24 Billion | - |
| Change in working capital | -312 Thousand | - | - | -312 Thousand | -312 Thousand | - |
| Other non-cash items | 705.31 Million | - | - | 705.31 Million | 705.31 Million | - |
| Investing Cash Flow | -6.11 Billion | - | - | -6.11 Billion | -6.11 Billion | - |
| Investments in PPE | -384 Thousand | - | - | -384 Thousand | -384 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | -1.15 Billion | - | - | -1.15 Billion | -1.15 Billion | - |
| Other Investing Activities | -4.95 Billion | - | - | -4.95 Billion | -4.95 Billion | - |
| Financing Cash Flow | 11.17 Billion | - | - | 11.17 Billion | 11.17 Billion | - |
| Debt repayment | -18.06 Billion | - | - | -18.06 Billion | -18.06 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 11.38 Billion | - | - | 11.38 Billion | 11.38 Billion | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 17.85 Billion | - | - | 17.85 Billion | 17.85 Billion | - |
| Accounts receivables | 1.48 Million | - | - | 1.48 Million | 1.48 Million | - |
| Accounts payables | -1.79 Million | - | - | -1.79 Million | -1.79 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 312 Thousand | - | - | 312 Thousand | 312 Thousand | - |
| Cash at beginning of period | 10.55 Billion | - | - | 10.55 Billion | 10.55 Billion | - |
| Cash at end of period | 10.2 Billion | - | - | 10.2 Billion | 10.2 Billion | - |
| Capital Expenditure | -384 Thousand | - | - | -384 Thousand | -384 Thousand | - |
| Effect of forex changes on cash | 990 Million | - | - | 990 Million | 990 Million | - |
| Net cash flow / Change in cash | -343.38 Million | - | - | -343.38 Million | -343.38 Million | - |
| Free Cash Flow | -6.39 Billion | - | - | -6.39 Billion | -6.39 Billion | - |
2337
SJM
ASEFA
STX
0VBE
PTGX